Other Species / Isoforms
  MOR-1 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S55-p
TGLGGSHsLCPQTGS
0 1
MOR-1 (human) TDLGGRDSLCPPTGS S57
MOR-1 iso5 (human) TDLGGRDSLCPPTGS S57
MOR-1 (mouse) TGLGGSHsLCPQTGS S55-p
MOR-1 (rat) TGLGGNDSLCPQTGS S55
T97
MYVIVRYTKMKTATN
1 0
MOR-1 (human) MYVIVRYTKMKTATN T99
MOR-1 iso5 (human) MYVIVRYTKMKTATN T99
MOR-1 (mouse) MYVIVRYTKMKTATN T97
MOR-1 (rat) MYVIVRYtKMKtAtN T97-p
T101
VRYTKMKTATNIYIF
1 0
MOR-1 (human) VRYTKMKTATNIYIF T103
MOR-1 iso5 (human) VRYTKMKTATNIYIF T103
MOR-1 (mouse) VRYTKMKTATNIYIF T101
MOR-1 (rat) VRYtKMKtAtNIyIF T101-p
T103
YTKMKTATNIYIFNL
1 0
MOR-1 (human) YTKMKTATNIYIFNL T105
MOR-1 iso5 (human) YTKMKTATNIYIFNL T105
MOR-1 (mouse) YTKMKTATNIYIFNL T103
MOR-1 (rat) YtKMKtAtNIyIFNL T103-p
Y106
MKTATNIYIFNLALA
2 0
MOR-1 (human) MKTATNIYIFNLALA Y108
MOR-1 iso5 (human) MKTATNIYIFNLALA Y108
MOR-1 (mouse) MKTATNIYIFNLALA Y106
MOR-1 (rat) MKtAtNIyIFNLALA Y106-p
Y166
CTMSVDRYIAVCHPV
3 0
MOR-1 (human) CTMSVDRyIAVCHPV Y168-p
MOR-1 iso5 (human) CTMSVDRYIAVCHPV Y168
MOR-1 (mouse) CTMSVDRYIAVCHPV Y166
MOR-1 (rat) CTMSVDRyIAVCHPV Y166-p
T180-p
VKALDFRtPRNAKIV
3 0
MOR-1 (human) VKALDFRTPRNAKII T182
MOR-1 iso5 (human) VKALDFRTPRNAKII T182
MOR-1 (mouse) VKALDFRtPRNAKIV T180-p
MOR-1 (rat) VKALDFRtPRNAKIV T180-p
S261
LMILRLKSVRMLSGS
2 2
MOR-1 (human) LMILRLKsVRMLsGs S263-p
MOR-1 iso5 (human) LMILRLKSVRMLSGS S263
MOR-1 (mouse) LMILRLKSVRMLSGS S261
MOR-1 (rat) LMILRLKsVRMLsGS S261-p
S266
LKSVRMLSGSKEKDR
3 2
MOR-1 (human) LKsVRMLsGsKEKDR S268-p
MOR-1 iso5 (human) LKSVRMLSGSKEKDR S268
MOR-1 (mouse) LKSVRMLSGSKEKDR S266
MOR-1 (rat) LKsVRMLsGSKEKDR S266-p
S268
SVRMLSGSKEKDRNL
0 2
MOR-1 (human) sVRMLsGsKEKDRNL S270-p
MOR-1 iso5 (human) SVRMLSGSKEKDRNL S270
MOR-1 (mouse) SVRMLSGSKEKDRNL S268
MOR-1 (rat) sVRMLsGSKEKDRNL S268
Y336-p
SCLNPVLyAFLDENF
Upstream
Downstream
3 0
Effects on Modified Protein
  • activity, induced
Effects on Biological Processes:
  • signaling pathway regulation
Putative in vivo kinases:
  • Src (human)
  • Src iso1 (mouse)
Treatment
  • morphine
  • naloxone
  • PP2
  • saracatinib
MOR-1 (human) SCLNPVLyAFLDENF Y338-p
MOR-1 iso5 (human) SCLNPVLYAFLDENF Y338
MOR-1 (mouse) SCLNPVLyAFLDENF Y336-p
MOR-1 (rat) SCLNPVLYAFLDENF Y336
S355
REFCIPTSSTIEQQN
1 0
MOR-1 (human) REFCIPTSSNIEQQN S357
MOR-1 iso5 (human) REFCIPTSSNIEQQN S357
MOR-1 (mouse) REFCIPTSSTIEQQN S355
MOR-1 (rat) REFCIPTsstIEQQN S355-p
S356
EFCIPTSSTIEQQNs
0 1
MOR-1 (human) EFCIPTSSNIEQQNs S358
MOR-1 iso5 (human) EFCIPTSSNIEQQNS S358
MOR-1 (mouse) EFCIPTSSTIEQQNs S356
MOR-1 (rat) EFCIPTsstIEQQNs S356-p
T357
FCIPTSSTIEQQNsA
1 1
MOR-1 (human) FCIPTSSNIEQQNsT N359
MOR-1 iso5 (human) FCIPTSSNIEQQNST N359
MOR-1 (mouse) FCIPTSSTIEQQNsA T357
MOR-1 (rat) FCIPTsstIEQQNsT T357-p
S363-p
STIEQQNsARIRQNt
Upstream
Downstream
11 6
Effects on Modified Protein
  • receptor recycling, induced
Kinase, in vitro:
  • PKCA (human)
  • PKCB iso2 (human)
  • PKCE (human)
  • PKCG (human)
Putative in vivo kinases:
  • PKCA (human)
Regulatory protein:
  • MOR-1 (mouse)
Treatment
  • DAMGO
  • etonitazene
  • fentanyl
  • morphine
  • phorbol_ester
  • Ro-32-0432
MOR-1 (human) SNIEQQNsTRIRQNt S365-p
MOR-1 iso5 (human) SNIEQQNSTRIRQNT S365
MOR-1 (mouse) STIEQQNsARIRQNt S363-p
MOR-1 (rat) stIEQQNsTRVRQNt S363-p
T370-p
sARIRQNtREHPstA
Upstream
Downstream
19 5
Effects on Modified Protein
  • molecular association, regulation
  • receptor desensitization, induced
  • receptor internalization, induced
  • receptor recycling, induced
Effects on Biological Processes:
  • endocytosis, induced
  • signaling pathway regulation
Putative in vivo kinases:
  • GRK2 (human)
  • GRK2 (mouse)
  • GRK3 (human)
  • GRK3 (mouse)
  • PKCA (human)
Putative upstream phosphatases:
  • PPP1CA (human)
Regulatory protein:
  • GRK2 (human)
  • GRK3 (human)
  • GRK5 (human)
  • GRK6 (human)
  • PKCA (human)
  • PKCA (mouse)
  • PKCB (mouse)
  • PKCB iso2 (mouse)
  • PKCE (mouse)
  • PKCG (mouse)
Treatment
  • BIM23627
  • Cmpd101
  • ConA
  • DAMGO
  • etonitazene
  • fentanyl
  • GRK2_inhibitor
  • H-89
  • LY333531
  • morphine
  • naloxone
  • NKH_477
  • painful stimulus
  • phorbol_ester
  • Ro-32-0432
  • siRNA
MOR-1 (human) sTRIRQNtRDHPstA T372-p
MOR-1 iso5 (human) STRIRQNTRDHPSTA T372
MOR-1 (mouse) sARIRQNtREHPstA T370-p
MOR-1 (rat) sTRVRQNtREHPsTA T370-p
S375-p
QNtREHPstANtVDR
Upstream
Downstream
24 5
MOR-1 (human)
S377-p
MOR-1 (mouse)
S375-p
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
  • receptor desensitization, induced
  • receptor internalization, induced
Effects on Biological Processes:
  • endocytosis, induced
  • signaling pathway regulation
Putative in vivo kinases:
  • GRK2 (human)
  • GRK2 (mouse)
  • GRK3 (human)
  • GRK3 (mouse)
  • GRK5 (human)
  • GRK5 (mouse)
Putative upstream phosphatases:
  • PPP1CA (human)
Regulatory protein:
  • GRK2 (human)
  • GRK3 (human)
  • GRK5 (human)
  • GRK6 (human)
  • MOR-1 (mouse)
  • RGS14 (mouse)
Treatment
  • SR-17018
  • acid wash
  • calyculin_A
  • Cmpd101
  • ConA
  • DAMGO
  • etonitazene
  • fentanyl
  • methadone
  • morphine
  • naloxone
  • NKH_477
  • okadaic_acid
  • oliceridine
  • oxycodone
  • painful stimulus
  • phorbol_ester
  • PZM21
  • Ro-32-0432
  • siRNA
MOR-1 (human) QNtRDHPstANtVDR S377-p
MOR-1 iso5 (human) QNTRDHPSTANTVDR S377
MOR-1 (mouse) QNtREHPstANtVDR S375-p
MOR-1 (rat) QNtREHPsTANTVDR S375-p
T376-p
NtREHPstANtVDRT
Upstream
Downstream
7 2
Effects on Modified Protein
  • molecular association, regulation
  • receptor internalization, induced
Effects on Biological Processes:
  • endocytosis, induced
  • signaling pathway regulation
Putative in vivo kinases:
  • GRK2 (human)
  • GRK2 (mouse)
  • GRK3 (human)
  • GRK3 (mouse)
Treatment
  • Cmpd101
  • DAMGO
  • etonitazene
  • fentanyl
  • morphine
  • naloxone
  • phorbol_ester
  • siRNA
MOR-1 (human) NtRDHPstANtVDRT T378-p
MOR-1 iso5 (human) NTRDHPSTANTVDRT T378
MOR-1 (mouse) NtREHPstANtVDRT T376-p
MOR-1 (rat) NtREHPsTANTVDRT T376
T379-p
EHPstANtVDRTNHQ
Upstream
Downstream
7 2
Effects on Modified Protein
  • molecular association, regulation
  • receptor desensitization, induced
  • receptor internalization, induced
Effects on Biological Processes:
  • endocytosis, induced
  • signaling pathway regulation
Putative in vivo kinases:
  • GRK2 (human)
  • GRK2 (mouse)
  • GRK3 (human)
  • GRK3 (mouse)
Treatment
  • Cmpd101
  • DAMGO
  • etonitazene
  • fentanyl
  • morphine
  • naloxone
  • phorbol_ester
  • siRNA
MOR-1 (human) DHPstANtVDRTNHQ T381-p
MOR-1 iso5 (human) DHPSTANTVDRTNHQ T381
MOR-1 (mouse) EHPstANtVDRTNHQ T379-p
MOR-1 (rat) EHPsTANTVDRTNHQ T379
T394-p
LENLEAEtAPLP___
Downstream
5 0
Effects on Modified Protein
  • receptor desensitization, induced
  • receptor internalization, induced
MOR-1 (human) LENLEAEtAPLP___ T396-p
MOR-1 iso5 (human) QPPLAVSMAQIFTRY M395
MOR-1 (mouse) LENLEAEtAPLP___ T394-p
MOR-1 (rat) LENLEAEtAPLP___ T394-p
-
gap
0 1
MOR-1 (human) gap -
MOR-1 iso5 (human) PPPTHREkTCNDYMK K410-m2
MOR-1 (mouse) gap -
MOR-1 (rat) gap -